Tech Company Financing Transactions

Ocular Therapeutix Funding Round

On 2/2/2011, Ocular Therapeutix raised $14 million in Series D investment from Ascension Ventures, Polaris Partners and SV Health Investors.

Transaction Overview

Company Name
Ocular Therapeutix
Announced On
2/2/2011
Transaction Type
Venture Equity
Amount
$14,000,000
Round
Series D
Investors

Ascension Ventures (Lead Investor) (Tara Butler)

Polaris Partners (Alan Crane)

SV Health Investors

Versant Ventures (Charles Warden)

Proceeds Purpose
The funding will be used to support Ocular Therapeutix's Phase II clinical trials across a variety of therapeutic areas. The first trial will be conducted to reinforce safety and test efficacy of their first sustained drug delivery system, a moxifloxacin-loaded punctum plug.

Company Information

Company Status
Publicly-held
Industry
Medical Devices & Instruments
Mailing Address
24 Crosby Dr.
Bedford, MA 01730
USA
Phone
877-628-8998
Website
www.ocutx.com
Email Address
[email protected]
Overview
Ocular Therapeutix, Inc. (NASDAQ: OCUL) is a company focused on the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology and ophthalmic surgery.
Profile
Ocular Therapeutix LinkedIn Company Profile
Social Media
Ocular Therapeutix Company Twitter Account
Company News
Ocular Therapeutix News
Facebook
Ocular Therapeutix on Facebook
YouTube
Ocular Therapeutix on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Antony Mattessich
  Antony Mattessich LinkedIn Profile  Antony Mattessich Twitter Account  Antony Mattessich News  Antony Mattessich on Facebook
Chief Financial Officer
Donald Notman
  Donald Notman LinkedIn Profile  Donald Notman Twitter Account  Donald Notman News  Donald Notman on Facebook
Chief Medical Officer
Michael Goldstein
  Michael Goldstein LinkedIn Profile  Michael Goldstein Twitter Account  Michael Goldstein News  Michael Goldstein on Facebook
Chief Scientific Officer
Peter Jarrett
  Peter Jarrett LinkedIn Profile  Peter Jarrett Twitter Account  Peter Jarrett News  Peter Jarrett on Facebook
VP - General Counsel
Jonathan Sparks
  Jonathan Sparks LinkedIn Profile  Jonathan Sparks Twitter Account  Jonathan Sparks News  Jonathan Sparks on Facebook
VP - Marketing
Scott Corning
  Scott Corning LinkedIn Profile  Scott Corning Twitter Account  Scott Corning News  Scott Corning on Facebook
VP - Product Management
Art Driscoll
  Art Driscoll LinkedIn Profile  Art Driscoll Twitter Account  Art Driscoll News  Art Driscoll on Facebook

 

 

Browse more venture capital transactions:

Prev: 2/2/2011: GraphEffect venture capital transaction
Next: 2/2/2011: Appolicious venture capital transaction

 

Share this article

 

About Our VC Transactions Data

We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.